Anavex Life Sciences has an EPS of $-0.6. In 2022, the company made an earnings per share (EPS) of $-0.62. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.6 | -3.23% |
2022 | -$0.62 | 14.81% |
2021 | -$0.54 | 20.00% |
2020 | -$0.45 | - |